The Colombo South Teaching Hospital is located in Kalubowila, Sri Lanka and mainly targets the treatment of the Dengue virus. It is the second largest hospital in the country. It is a teaching-oriented hospital that maintains a bed strength of 1,110.

There are 1,110 beds in Colombo South Teaching Hospital.

During the past decade, Colombo South Teaching Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Colombo South Teaching Hospital" are "Healthy Volunteers" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Colombo South Teaching Hospital" in a lesser frequency.

Most popular intervention types in "Colombo South Teaching Hospital" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials), "Placebo" (1 trials), "Telmisartan 20 mg/amlodipine 2.5 mg ." (1 trials), "Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials) and "Telmisartan 20 mg/indapamide 1.25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Colombo South Teaching Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Colombo South Teaching Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Colombo South Teaching Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Colombo South Teaching Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".